Amarin Corp. Plc (AMRN)

13.63 -0.08 (-0.58%) USD  |  NASDAQ  |  Sep 04, 16:00
13.58 -0.05 (-0.37%) After-Hours: 20:00
More

Amarin SG&A Expense (TTM) : 76.76M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 76.76M
March 31, 2026 92.35M
December 31, 2025 106.17M
September 30, 2025 121.28M
June 30, 2025 136.87M
March 31, 2025 170.29M
December 31, 2024 172.77M
September 30, 2024 179.46M
June 30, 2024 187.61M
March 31, 2024 168.13M
December 31, 2023 188.22M
September 30, 2023 210.40M
June 30, 2023 222.73M
March 31, 2023 251.12M
December 31, 2022 285.50M
September 30, 2022 315.06M
June 30, 2022 363.67M
March 31, 2022 392.11M
December 31, 2021 408.14M
September 30, 2021 433.47M
June 30, 2021 453.29M
March 31, 2021 438.91M
December 31, 2020 466.77M
September 30, 2020 446.29M
June 30, 2020 406.01M
Date Value
March 31, 2020 386.44M
December 31, 2019 324.81M
September 30, 2019 306.50M
June 30, 2019 274.50M
March 31, 2019 254.74M
December 31, 2018 226.04M
September 30, 2018 183.14M
June 30, 2018 166.50M
March 31, 2018 145.41M
December 31, 2017 134.39M
September 30, 2017 126.73M
June 30, 2017 117.35M
March 31, 2017 110.10M
December 31, 2016 103.74M
September 30, 2016 98.66M
June 30, 2016 101.25M
March 31, 2016 101.85M
December 31, 2015 98.68M
September 30, 2015 93.61M
June 30, 2015 86.38M
March 31, 2015 82.86M
December 31, 2014 81.21M
September 30, 2014 85.41M
June 30, 2014 94.23M
March 31, 2014 105.33M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. 1.352B
Alkermes Plc 841.17M
DBV Technologies SA 56.62M
Cellectis SA 21.32M
Akari Therapeutics Plc 8.796M